Caren Deardorf is Chief Commercial Officer of Dianthus Therapeutics Inc.
Person profile
Roles
Dianthus Therapeutics
Chief Commercial Officer
Crinetics Pharmaceuticals
Director
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Crinetics Pharmaceuticals, Inc.
21 Jun 23
4
Magenta Therapeutics, Inc.
2 Dec 22
4
Magenta Therapeutics, Inc.
1 Aug 22
4
Crinetics Pharmaceuticals, Inc.
21 Jun 22
4
Magenta Therapeutics, Inc.
6 Jun 22
4
Magenta Therapeutics, Inc.
19 May 22
4/A
Crinetics Pharmaceuticals, Inc.
4 Apr 22
4
Crinetics Pharmaceuticals, Inc.
14 Mar 22
3
Crinetics Pharmaceuticals, Inc.
14 Mar 22
4
Magenta Therapeutics, Inc.
17 Feb 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jun 23 | CRNX Crinetics Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 6,000 | 0.00 | 6,000 |
16 Jun 23 | CRNX Crinetics Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 20.32 | 17,500 | 355.60 k | 17,500 |
30 Nov 22 | DNTH Dianthus Therapeutics | Common Stock | Grant | Acquire A | No | No | 0.94 | 3,000 | 2.82 k | 19,762 |